Home › NDC Lookup › RxCUI directory › RxCUI 2679307

Vadadustat 150 MG Oral Tablet [Vafseo] — RxCUI 2679307

Name: Vadadustat 150 MG Oral Tablet [Vafseo] (RxCUI 2679307)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2679307 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2679307

Official nameVadadustat 150 MG Oral Tablet [Vafseo]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asVafseo 150 MG Oral Tablet

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)1,619 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Vadadustat 150 MG Oral Tablet [Vafseo] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Vadadustat 150 MG Oral Tablet [Vafseo] RxCUI 2679307 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Vadadustat 2679296 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vafseo 2679302 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Vadadustat Oral Tablet 2679300 SCDF
- Vadadustat Oral Product 2679298 SCDG
- Vadadustat Pill 2679299 SCDG
- Vadadustat Oral Tablet [Vafseo] 2679306 SBDF
- Vafseo Oral Product 2679304 SBDG
- Vafseo Pill 2679305 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Vadadustat 150 MG Oral Tablet 2679301 SCD
- Vadadustat 150 MG 2679297 SCDC
- Vadadustat 150 MG [Vafseo] 2679303 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Vadadustat 150 MG Oral Tablet SCD · 2679301
Vadadustat 150 MG SCDC · 2679297
Vadadustat Oral Tablet SCDF · 2679300
Vadadustat Oral Product SCDG · 2679298
Vadadustat Pill SCDG · 2679299

Brand-Name Concepts

Vadadustat 150 MG [Vafseo] SBDC · 2679303
Vadadustat Oral Tablet [Vafseo] SBDF · 2679306
Vafseo Oral Product SBDG · 2679304
Vafseo Pill SBDG · 2679305
Vafseo BN · 2679302

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2679307 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
59922-0641-60	1 BOTTLE in 1 CARTON (59922-641-60) / 60 TABLET, FILM COATE...	VAFSEO	Akebia Therapeutics, Inc.	2024-03-28
59922-0642-60	1 BOTTLE in 1 CARTON (59922-642-60) / 60 TABLET, FILM COATE...	VAFSEO	Akebia Therapeutics, Inc.	2024-03-28
59922-0643-60	1 BOTTLE in 1 CARTON (59922-643-60) / 60 TABLET, FILM COATE...	VAFSEO	Akebia Therapeutics, Inc.	2024-03-28

Observed labelers: Akebia Therapeutics, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0901	Vadadustat oral 1mg for esrd	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.